Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
2 drugs in development
By Therapeutic Area
top 2
R&D Momentum
40/100
Pipeline Velocity
15/100
Trial Completion Rate
80/100
Pipeline Concentration
38/100
Pipeline Freshness
81/100
Strategic Signals
Activity
Last 14 days
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Real-World Evidence Observational Study to Evaluate the Safety of iDose® TR (Travoprost Intracameral Implant) 75 µg in an Office-Based Surgery Setting
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Epioxa Hd/Epioxa Kit — PHOTREXA VISCOUS IN DEXTRAN 20%/PHOTREXA
Application NDA203324 (NDA)
Epioxa Hd/Epioxa Kit — EPIOXA HD/EPIOXA KIT
Application NDA219910 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)